Viemed Healthcare, Inc.

NASDAQ:VMD

Medical - Devices

Healthcare
$8.78 +0.68%

+$0.07 today

Market cap
$332.70M
Beta
1.13
P/E (TTM)
27.4
EPS (TTM)
$0.39
52W Low $5.93High $10.68

Volume 0.26M

Average 0.26M

VMD Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

Viemed Healthcare, Inc.NASDAQ: VMD

Gross Margin · Q1 FY2026 · quarter ended Mar 2026

Gross margin holds steady near 56.3%

Gross margin was 56.3% in Q1 FY2026, down 0.0 pp from a year earlier. On a trailing-twelve-month basis it was 57.3%, down 1.4 pp year over year. Over 3 fiscal years it narrowed by 3.5 pp.

Context

  • Gross margin widened in 1 of the last 3 fiscal years.
  • FY2025 was the lowest level in the 4 fiscal years shown.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
56.3%-1.6 pp QoQ
Last fiscal yearDec 2025
57.5%-1.9 pp YoY
LTMMar 2026
57.3%-1.4 pp YoY
Gross Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-0.0 pp——
1 year-1.9 pp——
3 years-3.5 pp——
5 years——
10 years——

Gross Margin history

Percent of revenue · from the income statement

Latest · FY2025
57.5%
Year-over-year change
-1.9pp

Gross Margin vs competitors

How VMD compares with its peers on the latest reported figures

  • VMD's LTM Mar 2026 gross margin of 57.3% is the 5th highest of the 11 companies compared; the peer median is 50.5%.
  • Its year-over-year change of -1.4 pp is the 8th highest of 11, against a peer median of +0.7 pp.
  • Over three fiscal years its change of -3.5 pp compares with a peer median of +3.6 pp.
VMD Competitors Peer median
Gross Margin for VMD and competitors
Company Period LTM level YoY 3-year change
SGHTSight Sciences, Inc.LTM Mar 202686.2% +0.5 pp+3.5 pp
CVRXCVRx, Inc.LTM Mar 202685.5% +1.8 pp+7.6 pp
ELMDElectromed, Inc.LTM Mar 202678.4% +0.9 pp+2.6 pp
SNWVSANUWAVE Health, Inc.LTM Mar 202675.7% -0.9 pp+3.0 pp
VMDViemed Healthcare, Inc.LTM Mar 202657.3% -1.4 pp-3.5 pp
SENSSenseonics Holdings, Inc.LTM Mar 202652.1% +44.9 pp+28.1 pp
MASS908 Devices Inc.LTM Mar 202649.0% -1.6 pp-7.9 pp
INGNInogen, Inc.LTM Mar 202648.7% +2.6 pp+6.9 pp
QTRXQuanterix CorporationLTM Mar 202644.1% -15.0 pp+3.7 pp
OMOutset Medical, Inc.LTM Mar 202640.6% +4.7 pp+23.7 pp
NNOXNano-X Imaging Ltd.LTM Dec 2025-98.2% -3.3 pp-18.0 pp
Peer median (excluding VMD) 50.5%+0.7 pp+3.6 pp

Competitors are the stored peer set for VMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue117.06M138.83M183.01M224.26M270.28M
Cost of Revenue43.65M54.15M70.23M91.05M114.82M
Gross Profit73.41M84.68M112.78M133.2M155.46M
Gross Margin62.7%61.0%61.6%59.4%57.5%
Research & Development2.11M2.7M2.78M3.07M3.02M
Selling, General & Admin60.04M73.36M93.73M112.48M130.5M
Operating Expenses61.83M76.43M98.45M115.3M134.75M
Depreciation & Amortization11.31M15.63M21.86M25.37M28.61M
EBITDA24.13M24.82M36.68M42.31M51.56M
EBITDA Margin20.6%17.9%20.0%18.9%19.1%
Operating Income11.58M8.25M14.33M17.9M20.71M
Operating Margin9.9%5.9%7.8%8.0%7.7%
Interest Income00000
Interest Expense318K197K424K776K1.18M
Other Income / Expenses923K738K61K(1.73M)1.06M
Income Before Tax12.5M8.99M14.39M16.17M21.77M
Pre-Tax Margin10.7%6.5%7.9%7.2%8.1%
Income Tax Expense3.38M2.77M4.15M4.76M6.39M
Net Income9.13M6.22M10.24M11.27M14.93M
Net Margin7.8%4.5%5.6%5.0%5.5%
EPS (Basic)0.230.150.270.290.38
EPS (Diluted)0.220.150.250.280.37
Weighted Avg Shares39.49M38.66M38.35M38.76M38.9M
Weighted Avg Shares (Diluted)40.68M39.81M40.38M40.81M40.82M

Viemed Healthcare, Inc.

NASDAQ:VMD

Intrinsic Alpha fair value

Locked

Current Price

$8.78

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.